| Karen Joan Hampton, LPC | |
|
296 Beauvoir Rd # 319, Biloxi, MS 39531-4051 | |
| (228) 456-3116 | |
| Not Available |
| Full Name | Karen Joan Hampton |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 296 Beauvoir Rd # 319, Biloxi, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003346784 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Joan Hampton, LPC 296 Beauvoir Rd # 319, Biloxi, MS 39531-4051 Ph: () - | Karen Joan Hampton, LPC 296 Beauvoir Rd # 319, Biloxi, MS 39531-4051 Ph: (228) 456-3116 |
News Archive
To date, little evidence has been documented regarding the immune responses after the onset of the symptoms or virus detection. Further, no cross-sectional studies have been conducted that define the time of infection. Thereby, no report is available that explains the relationship between the earliest immune responses to COVID-19 and temporal kinetics. New research deals with this research gap using blood transcriptomics, multiparameter flow cytometry, and T cell receptor (TCR) sequencing methods.
When pediatric patients are imaged using CT, reducing sedation and radiation dose while maintaining the best possible image quality is paramount in delivering care. To provide patients with high-quality CT exams and a reduction in sedation and radiation dose, leading children's hospitals are installing Toshiba America Medical Systems, Inc.'s Aquilion ONE 320-detector row CT system.
An international team of scientists has developed computational models to re-analyze and validate experimentally-derived publicly available macromolecular structures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
A tiny molecule found in most plant-based foods douses the flames before damaging lesions can form in the colon, according to a study by Texas AgriLife Research scientist Dr. Nancy Turner.
› Verified 1 days ago
Jennifer Neff, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1989 Pass Rd, Biloxi, MS 39531 Phone: 228-207-1248 Fax: 228-388-6182 | |
Taylor Ritchey, MS, LPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2620 Executive Pl, Biloxi, MS 39531 Phone: 228-385-7744 | |
Sindy R Crowe, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1046 Division St, Biloxi, MS 39530 Phone: 228-374-2494 | |
Mr. Anthony Williams, M.ED. Counselor Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5433 Fax: 228-523-4754 | |
Mrs. Shelbi Bradley, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1989 Pass Rd, Biloxi, MS 39531 Phone: 228-207-1248 | |
Mr. John William Graves, Counselor Medicare: Not Enrolled in Medicare Practice Location: 228 Rue Petit Bois, Biloxi, MS 39531 Phone: 228-388-7998 Fax: 228-388-9630 |